CU23908B1 - - Google Patents

Info

Publication number
CU23908B1
CU23908B1 CU20100119A CU20100119A CU23908B1 CU 23908 B1 CU23908 B1 CU 23908B1 CU 20100119 A CU20100119 A CU 20100119A CU 20100119 A CU20100119 A CU 20100119A CU 23908 B1 CU23908 B1 CU 23908B1
Authority
CU
Cuba
Application number
CU20100119A
Other versions
CU20100119A7 (es
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40377437&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CU23908(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of CU20100119A7 publication Critical patent/CU20100119A7/es
Publication of CU23908B1 publication Critical patent/CU23908B1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
CU2010000119A 2007-12-12 2010-06-11 Compuestos orgánicos de aminotiazoles CU20100119A7 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1312207P 2007-12-12 2007-12-12
US2470908P 2008-01-30 2008-01-30
PCT/EP2008/067220 WO2009074605A1 (en) 2007-12-12 2008-12-10 Aminothiazoles and their uses

Publications (2)

Publication Number Publication Date
CU20100119A7 CU20100119A7 (es) 2011-10-14
CU23908B1 true CU23908B1 (es) 2013-06-28

Family

ID=40377437

Family Applications (1)

Application Number Title Priority Date Filing Date
CU2010000119A CU20100119A7 (es) 2007-12-12 2010-06-11 Compuestos orgánicos de aminotiazoles

Country Status (26)

Country Link
US (4) US8426356B2 (es)
EP (1) EP2229386B1 (es)
JP (2) JP5286366B2 (es)
KR (2) KR101187111B1 (es)
CN (1) CN101945866B (es)
AR (1) AR069628A1 (es)
AU (1) AU2008334659A1 (es)
BR (1) BRPI0821138A2 (es)
CA (1) CA2708793C (es)
CL (1) CL2008003688A1 (es)
CO (1) CO6290661A2 (es)
CR (1) CR11469A (es)
CU (1) CU20100119A7 (es)
EA (2) EA201400280A1 (es)
EC (1) ECSP10010244A (es)
ES (1) ES2542878T3 (es)
GT (1) GT201000166A (es)
HN (1) HN2010001176A (es)
IL (1) IL206104A (es)
MA (1) MA31869B1 (es)
MY (1) MY156466A (es)
NZ (1) NZ585788A (es)
PE (1) PE20091108A1 (es)
TN (1) TN2010000254A1 (es)
TW (1) TWI430804B (es)
WO (1) WO2009074605A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20080103A1 (es) * 2006-05-31 2008-04-03 Novartis Ag AMINOTIAZOLES COMO MODULADORES DEL FACTOR DE ELONGACION EF-Tu
CA2708793C (en) * 2007-12-12 2016-06-21 Novartis Ag Aminothiazoles and their uses
WO2016081825A1 (en) * 2014-11-21 2016-05-26 KamTek, Inc. Methods and compositions for treating clostridium difficile associated disease

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202241A (en) 1988-09-09 1993-04-13 Gruppo Lepetit S.P.A. Antibiotic GE 2270
ES2066914T3 (es) 1989-07-04 1995-03-16 Lepetit Spa Factores a1, a2, a3 y h del antibiotico ge 2270.
DK0451486T3 (da) 1990-03-08 1995-05-08 Lepetit Spa Antibiotikum GE 2270 faktorer B1, B2, C1, C2, D1, D2, E og T
IL100572A (en) 1991-01-03 1997-01-10 Lepetit Spa Amides of antibiotic ge 2270 factors their preparation and pharmaceutical compositions containing them
DE69224497T2 (de) 1991-08-30 1998-07-02 Biosearch Italia Spa Faktor C2a des Antibiotikums CE 2270
US5882900A (en) 1992-09-10 1999-03-16 Gruppo Lepetit S.P.A. Process for the selective increase of production of antibiotic GE 2270 factor a by adding vitamin B12 to nutrient medium
DE69317058T2 (de) 1992-12-22 1998-06-10 Biosearch Italia Spa Die antibiotika ge 37468 a, b und c
WO1996014427A1 (en) 1994-11-08 1996-05-17 Gruppo Lepetit S.P.A. Microbial transformation process for obtaining antibiotic ge 2270 factor d¿2?
JP3518606B2 (ja) 1995-02-07 2004-04-12 バイオサーチ・イタリア・ソチエタ・ペル・アチオニ Ge2270及びge2270−様抗生物質の塩基性オキサゾリン−アミド誘導体
ATE165101T1 (de) 1995-02-07 1998-05-15 Biosearch Italia Spa Basische prolinamid derivate von ge2270 und ge2270-ahnlichten antibiotika
EP0880541B1 (en) 1996-02-14 2003-01-15 Biosearch Italia S.p.A. Derivatives of antibiotic ge2270 factors
JPH1059997A (ja) 1996-08-22 1998-03-03 Microbial Chem Res Found アミチアマイシンアミド誘導体
DK1553967T3 (da) 2002-06-17 2011-08-29 Naicons S C A R L Anvendelse af et amidderivat af GE 2270 faktor A3 til behandling af acne
AU2005327139A1 (en) 2004-09-22 2006-08-17 Merck & Co., Inc. Antibiotic compound
WO2007007399A1 (ja) * 2005-07-13 2007-01-18 Taisho Pharmaceutical Co., Ltd. チアゾール系化合物
PE20080103A1 (es) 2006-05-31 2008-04-03 Novartis Ag AMINOTIAZOLES COMO MODULADORES DEL FACTOR DE ELONGACION EF-Tu
WO2008082562A2 (en) 2006-12-20 2008-07-10 Novartis Ag Aminothiazole macrocycles, their use as antibacterial compounds and processes for their production
AU2008258639B2 (en) 2007-06-04 2012-07-05 Novartis Ag Macrocycles and their uses
CA2708793C (en) * 2007-12-12 2016-06-21 Novartis Ag Aminothiazoles and their uses

Also Published As

Publication number Publication date
PE20091108A1 (es) 2009-08-24
EP2229386A1 (en) 2010-09-22
US20090156628A1 (en) 2009-06-18
US8426356B2 (en) 2013-04-23
CO6290661A2 (es) 2011-06-20
IL206104A0 (en) 2010-11-30
TN2010000254A1 (en) 2011-11-11
ECSP10010244A (es) 2010-07-30
TW200932256A (en) 2009-08-01
CN101945866A (zh) 2011-01-12
AR069628A1 (es) 2010-02-03
ES2542878T3 (es) 2015-08-12
AU2008334659A1 (en) 2009-06-18
BRPI0821138A2 (pt) 2015-06-16
KR101187111B1 (ko) 2012-09-28
HN2010001176A (es) 2012-12-10
EP2229386B1 (en) 2015-06-03
US9492496B2 (en) 2016-11-15
US20170015704A1 (en) 2017-01-19
EA201000890A1 (ru) 2011-02-28
US20140274878A1 (en) 2014-09-18
MY156466A (en) 2016-02-26
WO2009074605A1 (en) 2009-06-18
KR20100090809A (ko) 2010-08-17
CN101945866B (zh) 2013-06-19
IL206104A (en) 2015-03-31
MA31869B1 (fr) 2010-11-01
KR20120047335A (ko) 2012-05-11
JP2013189468A (ja) 2013-09-26
EA201400280A1 (ru) 2014-08-29
NZ585788A (en) 2011-07-29
US20130231275A1 (en) 2013-09-05
GT201000166A (es) 2012-04-30
CL2008003688A1 (es) 2009-06-19
TWI430804B (zh) 2014-03-21
CU20100119A7 (es) 2011-10-14
CA2708793A1 (en) 2009-06-18
CR11469A (es) 2010-07-09
EA020205B1 (ru) 2014-09-30
JP5286366B2 (ja) 2013-09-11
JP2011506394A (ja) 2011-03-03
CA2708793C (en) 2016-06-21

Similar Documents

Publication Publication Date Title
BRPI0819773A2 (es)
CN300729898S (zh) 电动车轮毂(五星前轮)
CN300728763S (zh) 墙纸(18)
CN300728462S (zh) 烟灰缸(3012)
CN300726997S (zh) 集装箱
CN300727533S (zh) 六氟化硫负荷开关侧倒柜
CN300730346S (zh) 瓶贴
CN300728854S (zh) 坐卧二用沙发(9870)
CN300729706S (zh) 首饰链(hy-an0040)
CN300730357S (zh) 瓶贴(米婆婆泰糯)
CN300729323S (zh) 插扣(jab1020)
CN300730351S (zh) 包装标贴
CN300728926S (zh) 桌子(6)
CN300729870S (zh) 金属轮毂(537)
CN300728430S (zh) Led投光灯(方型lve-f240-24rgb)
CN300726337S (zh) 班椅(oc-18)
CN300874877S (zh) T恤(4)
CN300937196S (zh) 照明器
CN300729070S (zh) 盘(正方芳香)
CN300860356S (zh) 绣花窗帘布(35)
CN300728994S (zh) 床头(3)
CN300728429S (zh) Led投光灯(lve-f480-48rgb\方型)
CN300729281S (zh) 包装容器
CN300728760S (zh) 墙纸(11a)
CN300730379S (zh) 展柜(g-11-a)

Legal Events

Date Code Title Description
FG Grant of patent
FD Lapse (for not paying fees)